[O16] Oral Session 16　Clinical Trial Facilitation Program

[O16-4] がんゲノム中核病院におけるがんゲノムプロファイリングに対する人的資源およびコストを考える

^○Yusuke Ohkuma¹, Natsuko Okita¹, Kinosita Ichiro², Shirota Hidekazu³, Nakayama Akiko⁴, Ueno Hideki⁵, Hayashi Hideyuki⁶, Tanabe Masahiko⁷, Mamesaya Nobuaki⁸, Kokuryo Toshio⁹, Matsumoto Shigemi¹⁰, Sakai Daisuke¹¹, Kochi Mariko¹², Ito Mamoru¹³, Tuchihara Kazuya⁵, Muto Manabu¹¹ (1.Section of Liaison for Cancer Genomic Medicine Hospitals, Center for Cancer Genomic and Advanced Therapeutics, National Cancer Center, 2.Division of Clinical Cancer Genomics, Hokkaido Univeristy Hospital, 3.Department of Clinical OncologyTohoku Univeristy Hospital, 4.Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Hospital East, 5.Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, 6.Keio Cancer Center, Keio Univeristy Hospital, 7.Department of Breast and Endocrine Surgery, The University of Tokyo Hospital, 8.Division of Thoracic Oncology, Shizuoka Cancer Center, 9.Medical Genomics Center, Nagoya Univeristy Hospital, 10.Department of Therapeutic Oncology, Kyoto Univeristy Hospital, 11.Center for Cancer Genomics and Personalized Medicine, Osaka Univeristy Hospital, 12.Department of Clinical Genetics and Genomic Medicine, Okayama Univeristy Hospital, 13.Department of Medicine and Biosystemic Science, Kyushu Univeristy Hospital)